US OptionsDetailed Quotes
BIVI250117P5000
- 4.60
- 0.000.00%
15min DelayClose Aug 5 16:00 ET
0.00High0.00Low
0.00Open4.60Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover0.00%IV80.00%PremiumJan 17, 2025Expiry Date3.00Intrinsic Value100Multiplier-5DDays to Expiry1.60Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
BioVie Stock Discussion
Sign in to post a comment
$BioVie (BIVI.US)$
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie (NASDAQ: BIVI) announced the acceptance of an abstract detailing their planned Phase 2 trial of bezisterim for Long COVID treatment at the Demystifying Long COVID International Conference in Barcelona. The study, fully funded by the U.S. Department of Defense, will be a double-blind, randomized, placebo-controlled tri...
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie (NASDAQ: BIVI) announced the acceptance of an abstract detailing their planned Phase 2 trial of bezisterim for Long COVID treatment at the Demystifying Long COVID International Conference in Barcelona. The study, fully funded by the U.S. Department of Defense, will be a double-blind, randomized, placebo-controlled tri...
2
1
$BioVie (BIVI.US)$ Earning report after bell today?
2
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$BioVie (BIVI.US)$ $Dutch Bros (BROS.US)$ $Freshworks (FRSH.US)$ $Laird Superfood (LSF.US)$ $Guardant Health (GH.US)$ $Bluejay Diagnostics (BJDX.US)$ $Emergent BioSolutions (EBS.US)$ $Ensysce Biosciences (ENSC.US)$ $Lyft Inc (LYFT.US)$ $Applovin (APP.US)$ $Interactive Strength (TRNR.US)$ $AtlasClear (ATCH.US)$ $MDJM Ltd (MDJH.US)$
📊⚡️📊
📊⚡️📊
$BioVie (BIVI.US)$ Reuters· just
Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded
Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded
1
$BioVie (BIVI.US)$
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BioVie Inc (NASDAQ: BIVI) announced the pricing of a registered direct offering of 1,146,000 shares of common stock at $2.83 per share, aiming to raise approximately $3.2 million in gross proceeds. The offering, priced at-the-market under Nasdaq rules, is expected to close around October 29, 2024. The company plans to use the net proceeds for working capital and general corpo...
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BioVie Inc (NASDAQ: BIVI) announced the pricing of a registered direct offering of 1,146,000 shares of common stock at $2.83 per share, aiming to raise approximately $3.2 million in gross proceeds. The offering, priced at-the-market under Nasdaq rules, is expected to close around October 29, 2024. The company plans to use the net proceeds for working capital and general corpo...
1
2
$BioVie (BIVI.US)$ can it break 3.5?
No comment yet
Onirac : wtf is wrong with bivi?